Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr945 Inhibitors

Olfr945, belonging to the olfactory receptor family 8 subfamily G, is a G-protein-coupled receptor (GPCR) crucial for the olfactory system in Mus musculus. This receptor type is essential for the detection and transduction of odorant signals, which lead to the perception of smell. Characterized by a 7-transmembrane domain structure, Olfr945, like other olfactory receptors, binds to specific odorant molecules, triggering a cascade of intracellular events culminating in a neuronal response. This process is fundamental to the olfactory system's ability to discern a vast array of scents, underscoring the significance of receptors like Olfr945 in the sense of smell. Inhibiting the function of Olfr945 involves strategies that either directly block its interaction with odorant molecules or indirectly modulate its signaling pathways or cellular environment. Direct inhibition would entail interfering with the ligand-binding domain of Olfr945, thereby preventing the initiation of G-protein-mediated signal transduction. This approach demands a high degree of specificity to avoid unintended effects on other GPCRs. Indirect inhibition encompasses a wider range of tactics, including altering the receptor's membrane dynamics or conformation, which can affect its ability to bind ligands or activate G-proteins. Furthermore, targeting the downstream signaling pathways or regulatory mechanisms of the receptor can modify its activity. This might include influencing the pathways that regulate receptor desensitization, internalization, or recycling, thereby affecting the receptor's signaling efficacy. The chemicals listed above represent potential indirect inhibitors of Olfr945, each acting through different mechanisms, such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, and alteration of G-protein coupling. The exploration of the function and inhibition mechanisms of Olfr945 not only enhances our understanding of olfactory transduction but also contributes to the broader field of GPCR research. The specificity and diversity of olfactory receptors, including Olfr945, highlight the complexity of targeting these receptors for modulation. Both direct and indirect inhibition strategies are crucial for advancing our knowledge of GPCR-mediated signal transduction, providing insights into the intricate network of interactions that govern olfactory perception and the potential modulation of these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Miconazole

22916-47-8sc-204806
sc-204806A
1 g
5 g
$65.00
$157.00
2
(1)

Miconazole, an antifungal agent, inhibits cytochrome P450 enzymes, disrupting steroid synthesis. This can affect GPCR function, including olfactory receptors like Olfr945, by altering membrane lipid composition and receptor conformation.

Nadolol

42200-33-9sc-253175
1 g
$180.00
(1)

Nadolol, a non-selective beta-adrenergic blocker, impacts GPCR-mediated signaling. This can lead to altered G-protein coupling efficiency in receptors like Olfr945, indirectly affecting their olfactory signal transduction.

Olanzapine

132539-06-1sc-212469
100 mg
$130.00
6
(1)

Olanzapine, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr945 activity in olfaction.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$80.00
$326.00
1
(0)

Ondansetron, a selective serotonin 5-HT3 receptor antagonist, indirectly affects GPCR signaling pathways. Its action on serotonin receptors can influence G-protein coupling in receptors like Olfr945, altering their signal transduction.

Metoprolol Tartrate

56392-17-7sc-205751
sc-205751A
5 g
25 g
$105.00
$238.00
3
(1)

Metoprolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr945 function.

Buprenorphine

52485-79-7sc-507499
1 mL
$42.00
(0)

Buprenorphine, a partial opioid receptor antagonist, influences GPCR signaling by blocking opioid receptors. This can lead to changes in GPCR-mediated signaling cascades, potentially affecting receptors like Olfr945.

Rabeprazole

117976-89-3sc-204872
sc-204872A
10 mg
25 mg
$342.00
$608.00
2
(1)

Rabeprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By affecting gastric acid secretion, it influences the histamine-mediated modulation of GPCRs, potentially impacting Olfr945 signaling.

Labetalol

36894-69-6sc-484723
50 mg
$176.00
(0)

Labetalol, a mixed alpha/beta adrenergic antagonist, modulates GPCR signaling pathways. Its action on both alpha and beta receptors can indirectly affect the signaling of GPCRs like Olfr945.

Propafenone Hydrochloride

34183-22-7sc-204863
sc-204863A
sc-204863B
sc-204863C
1 g
5 g
25 g
100 g
$21.00
$65.00
$194.00
$491.00
(1)

Propafenone, an antiarrhythmic agent, can influence GPCR function due to its beta-blocker properties. This can lead to indirect modulation of GPCR signaling pathways, potentially affecting Olfr945.